Clinical Trials in Chicago

Showing 10161-10180 of 20,493 trials

Fetal Pulse Oximetry Trial (FOX)

NCT00098709

The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.

Pregnancy

The George Washington University Biostatistics Center10,000 participantsStarted May 2002

Birmingham, Alabama, United States • Chicago, Illinois, United States • Detroit, Michigan, United States +10 more locations

COMPLETEDNA2.2 miles

Atalante USAbility

NCT05284708

The "USAbility" study - Human Factor Validation Testing of the Atalante exoskeleton aims at demonstrating that Atalante can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.

Hemiplegia

Wandercraft20 participantsStarted Nov 2021

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

NCT01232283

This study will evaluate the effects of an experimental (being tested) study drug called apremilast. Apremilast works by lowering some of the chemicals that affect psoriasis and therefore improves the symptoms of psoriasis. The purpose of this study is to test apremilast and compare its effects to placebo (an inactive substance which contains no medicine but is in the same form as the drug). This study will test efficacy (improvement of signs and symptoms) and safety of apremilast in patients with moderate to severe psoriasis.

Plaque Psoriasis

Amgen413 participantsStarted Nov 2010

Phoenix, Arizona, United States • Hot Springs, Arkansas, United States • Bakersfield, California, United States +43 more locations

Fetal Pulse Oximetry Trial (FOX)

Atalante USAbility

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

Find Trials by Condition in Chicago

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Adaptive COVID-19 Treatment Trial (ACTT)

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants

A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Narcotic vs. Non-narcotic Pain Study Protocol

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia